Skip to content

The effect of transcutaneous vagus nerve stimulation on early postoperative neurocognitive dysfunction in elderly patients undergoing lower limb joint replacement surgery under general anesthesia

The effect of transcutaneous vagus nerve stimulation on early postoperative neurocognitive dysfunction in elderly patients undergoing lower limb joint replacement surgery under general anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500099783
Enrollment
Unknown
Registered
2025-03-28
Start date
2025-04-01
Completion date
Unknown
Last updated
2025-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative cognitive dysfunction

Interventions

Experimental group:30 minutes before surgery (preoperative preparation room), 60 minutes during surgery (after anesthesia induction), and 30 minutes after surgery (anesthesia resuscitation room) were
control group:30 minutes preoperatively (preoperative preparation room), 60 minutes intraoperatively (after anesthesia induction), and 30 minutes postoperatively (anesthesia resuscitation room) using

Sponsors

Huzhou Center Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >=65 years old; 2.American Society of Anesthesiology (ASA) Physical Conditions I-III; 3.Body Mass Index (BMI) 18~30 kg/m^2; 4.Hip or knee replacement surgery; 5.general anesthesia;

Exclusion criteria

Exclusion criteria: 1.Cognitive impairment determined by preoperative Mini Mental State Examination (MMSE) (less than 17 for illiterate individuals, less than 20 for those with primary school education or above, and less than 24 for those with high school education or above) or Montreal Cognitive Assessment (MoCA) [score<23 (one point can be added for<12 years of education)]; 2.Unable to communicate due to aphasia, severe hearing impairment, or other difficulties; 3.Use of psychotropic drugs (such as chlorpromazine, risperidone, olanzapine, haloperidol, and chlorpromazine); 4.Patients with a history of alcohol abuse or use of acetylcholine drugs; 5.During the study, sevoflurane, dexmedetomidine, scopolamine, and pentylethyl ether hydrochloride were used; 6.Severe circulatory system diseases (such as severe arrhythmia, hypertension, coronary artery disease, heart failure) and history of cardiac surgery; 7.Severe respiratory system diseases (respiratory failure, severe chronic obstructive pulmonary disease); 8.History of cerebral hemorrhage; 9.Coagulation abnormality; 10.Patients who refuse to use vagus nerve stimulation; 11.Patients with severe subcutaneous emphysema and serious adverse events (such as intraoperative bleeding and severe hemodynamic fluctuations); 12.Emergency operation; 13.Postoperative admission to ICU; 14.Decided to withdraw from the study during the research period; 15.Second surgery within 3 days after surgery;

Design outcomes

Primary

MeasureTime frame
Delayed neurocognitive recovery (DNR);

Secondary

MeasureTime frame
Postoperative delirium;Postoperative Pain;Postoperative sleep quality;Postoperative anxiety score;Postoperative side effects;

Countries

China

Contacts

Public ContactKeyu Fan

Huzhou Center Hospital

215535169@qq.com+86 17398381638

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026